For the third year, the FDA has slowed down its fast track approvals for new drugs with the agency offering 11 treatments with the designation in the first half of 2022.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,